GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,391 Cr | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr |
What is the latest Cash and Bank ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹1,391 Cr |
| Mar2025 | ₹1,404 Cr |
| Mar2024 | ₹1,063 Cr |
| Mar2023 | ₹1,156 Cr |
| Mar2022 | ₹2,485 Cr |
How is Cash and Bank of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,391 Cr | -0.89 | |
| Mar2025 | ₹1,404 Cr | 32.01 | |
| Mar2024 | ₹1,063 Cr | -8.02 | |
| Mar2023 | ₹1,156 Cr | -53.47 | |
| Mar2022 | ₹2,485 Cr | - | |
Compare Cash and Bank of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,823.7 Cr | -0.3% | 10.4% | -28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.3% |
10.4% |
-28.3% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses